Indegene per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024
₹17.12₹16.72₹17.15₹15.19
₹17.01₹16.62₹17.02₹15.07
₹130.51₹130.51₹109.21₹64.37
₹171.76₹145.97₹118.55₹116.65
—₹27.06₹18.45₹22.87
₹25.22₹25.22₹17.20₹22.39
—₹2.00₹0.00₹0.00
24.124.124.022.2
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

INDGN₹598.95

Indegene Ltd.

· Pharma & Health
₹ CrorePeersSYNGENELTTSGRANULESJUBLPHARMAKIMSERISEMCUREONESOURCEMcap ₹14,405 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS15.1917.1516.7217.12
Diluted EPS15.0717.0216.6217.01
Book Value per Share64.37109.21130.51130.51
Revenue per Share116.65118.55145.97171.76
Cash Flow per Share22.8718.4527.06—
Free Cash Flow per Share22.3917.2025.2225.22
Dividends per Share0.000.002.00—
Shares Outstanding (cr)22.224.024.124.1
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.